Previous 10 |
On September 28, 2018, Tekla Life Sciences Investors paid a distribution of $0.40 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return of capital or other capital source. The composition of this and subsequent distributi...
On September 28, 2018, Tekla Healthcare Investors paid a distribution of $0.47 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it ma...
By Evan McCulloch, Senior Vice President, Director of Research Franklin Equity Group ® Portfolio Manager, Franklin Biotechnology Discovery Fund Franklin Equity Group's Evan McCulloch explains why higher rates of drug utilization and healthcare spending are lending support to the b...
Over the past few weeks, I have written a few articles about the income opportunities provided by Tekla's healthcare funds. Thus far, I have covered three of the four funds, so it seems a good time to take a look at the fourth. That fourth fund is called Tekla Life Sciences Investors ( HQL ) a...
(Editors' Note: This article is meant as an introduction for The Formula , a new Marketplace service by Clover Biotech Research.) The Formula Welcome To Seeking Alpha's Next Big Community! Your subscription and confidence in our service are important to me. While I cannot promise por...
Chen Lin and Michael Oliver return as guests on the radio program. Chen who has a legendary investing track record shares some of his latest biotech ideas and Michael provides his latest insights into gold and other key markets. Chen Lin , had been a doctoral candidate in ae...
News, Short Squeeze, Breakout and More Instantly...
TeklaLife Sciences Investors Company Name:
HQL Stock Symbol:
NYSE Market:
TeklaLife Sciences Investors Website:
2024-08-01 06:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-25 05:00:37 ET Few people pay much attention to the management team of a closed-end fund (CEF). But it’s becoming a much more critical factor driving CEF upside (and downside!), as well as these funds’ 8%+ dividend payouts. I was reminded of this recently by a ...
PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / abrdn Life Sciences Investors ("HQL") announced today the results of the Annual Meeting of Shareholders (the "Meeting"), held on June 25, 2024. As of the record date, April 1, 2024, HQL had outstanding 27,350,517 shares of common stock. 87.84% o...